A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Rai, Yogesh
- Evaluation of Drug Therapy in Cataract Surgery at Saraswathi Institute of Medical Sciences, Ghaziabad, U.P., India
Authors
1 Department of Pharmacology, Saraswati Institute of Medical Sciences, Hapur, Ghaziabad, U.P., IN
2 Department of Ophthalmology, Saraswati Institute of Medical Sciences, Hapur, Ghaziabad, U.P., IN
3 Department of Biochemistry, Saraswati Institute of Medical Sciences, Hapur, Ghaziabad, U.P., IN
4 Department of Pharmacology of Saraswati Institute of Medical Sciences, Hapur, Ghaziabad, U.P., IN
Source
Indian Journal of Public Health Research & Development, Vol 4, No 1 (2013), Pagination: 197-201Abstract
Objective: To study the prescribing pattern in cataract surgery patients in SIMS, for evaluation of their pharmacoepidemiology.
Material and methods: A retrospective study was conducted in the department of Pharmacology in collaboration with the department of Ophthalmology for a period of one year. Total 720 patients were analysed. Utilisation pattern of drugs like dosages form, route, frequency of administration and duration of therapy in preoperative, intraoperative and postoperative were audited. Drug prescription versus therapeutic indication was also evaluated.
Result: Different antibiotics mostly Fluoroquinolones, (like moxifloxacine (71.11%), gatifloxacine (16.66%), ofloxacin (4.16%) and, antiinflammatory drugs-bromofenac (54.27%), flurbiprofen (45.27%) and mydriatic-cucloplegic agents were prescribed.
Conclusion: The prescription was logical in respect of therapeutic indication. But in view of cost Moxifloxacin and Bromofenac could have been replaced by cheaper antibiotics and antiinflammtory drugs as Ofloxacin and Flurbiprofen.
References
- Hooper D. Quinolones. In: Mandell GL, Bennett JE, Dolin R. Mandell, 5thed. Philadelphia: Churchill Livingstone, 2000:404–23.
- Hooper DC, Wolfson JS. 2d ed. Washington, D.C.: American Society for Microbiology, 1993:53–7.
- Hooper DC. Drugs. 1999;58(suppl 2):6–10.
- Turnidge J. . Drugs. 1999;58(suppl 2):29–36.
- Hackbarth CJ, Chambers HF, Sande MA. Antimicrob Agents Chemother. 1986;29:611–3.
- Walker RC. The fluoroquinolones. Mayo Clin Proc. 1999;74:1030–1037.
- Alghasham AA, Nahata M. Ann Pharmacother. 1999;33:48–60.
- Owens RC Jr, Ambrose PG. Med Clin North Am. 2000;84:1447–69.
- Hooper DC. Clin Infect Dis. 2000;30:243–54.
- Ambrose PG, Owens RC . Conn Med. 1997;61:269–72.
- Kaur, I.P. and Smitha. R., dope Develop. Ind. Pharm., 2002 28. 353.
- Keistea, J.C., Cooper, E.R., Missel, P.J., Long, J.C. and Hager, D.F. J. Pharm. Sci, 1991, 80,50.
- Khopade, A.J. and Jain, N.K., Pharmazie, 19%. 50, 812.
- Kumar, S., Haglund, B.O. and Himmelstein, K.J., J. Ocul. Pharmcol., 1994,10,47.
- Kurz, D. and Ciullla, T.A., Ophthalmic Clin. North. Amer.. 2002,15.405.
- Latorre F. and Nicolal, A.P., doctor prescribed drugs Exp, Clin, Res.. 1998, 24, 153.
- Lee, V.H.L. and Robinson, J.R., J. Ocul. Pharmacol., 1986, 2, 67.
- Lin. H.R. and Sung. K.C., J. Contol. release, 2000, 69, 379.
- lnduPal. K. and Meenakshi, K., dope Develop. Ind. Pharm., 2002, 473.
- Marshall. W.S. and Klyee, S.D., J. membrane layer Biol., 1983, 73, 275.
- Meseuger, G., Gumy, R., Buri, P., Rozier, A. and Plazonnet, B., Int. J. Pharm., 1993, 95, 229.
- Middleton, D.L, Leung, S.H.S. and Robinson, J.R., In; Lenaerts,V and Gummy, R., Eds., Bioadhesive dope Delivery Systems, CRC Press, Boca Raton., 1990. 203.
- Monem, A.S, Ali, FM. and Ismail. M W .Int. J. Pherm., 2000 198, 20.
- Nagarsenker, M.S., Londhe, VY. and Nadkarni. G D. Int. J. Pharm., 1999, 190, 63.
- Rathore K.S., Nema R.K., “Management of Glaucoma: a review” worldwide diary of Pharm Tech Research, Vol.1, No.3, pp, July-Sept. 2009.
- A Study of Incidence of Fulminant Hepatic Failure in Paeditric Age Group and Knowledge, Behaviour & Attitude Regarding Etiology of Jaundice in Society
Authors
1 Department of Pediatrics, Saraswathi Institute of Medical Sciences, Anwarpur, Hapur, (Uttar Pradesh), IN
2 Department of Pathology, Saraswathi Institute of Medical Sciences, Anwarpur, Hapur, (Uttar Pradesh), IN
3 Department of Biochemistry, Saraswathi Institute of Medical Sciences, Anwarpur, Hapur, (Uttar Pradesh), IN
Source
Indian Journal of Public Health Research & Development, Vol 3, No 3 (2012), Pagination: 42-45Abstract
Object: To study the incidence and etiology of fulminant hepatic failure (FHF) in children and to study, attitude, behavior and knowledge regarding etiology and treatment of jaundice among the accompanying persons of cases of Jaundice.
Material & methods: The present study was conducted in the Department of Pediatrics, Saraswathi Institute of Medical Sciences (SIMS), Anwarpur, Hapur. 38570 children between 6 months to 18 years of age belonging to both rural and urban areas with signs and symptoms suggestive of liver disease and Children who fulfilled diagnostic criteria of FHF were included. Children were investigated for incidence and etiology of liver disease. A questionnaire was prepared to study the knowledge, attitude and behavior regarding etiology and treatment of jaundice among the accompanying persons of Jaundice Patients.
Result: Incidence of FHF was 1.4 per 1000 per year. Out of total 1010 jaundiced patients, incidence of FHF was 2.5%. Cases of FHF were maximum 61.1% in 5-15 year age group, Male: female ratio was almost equal in case of FHF (1.25:1). In our study etiological diagnosis was possible in 68.48% cases, out of which 61.08% were of viral etiology. 31.48%were idiopathic. Drug induced FHF was in 7.4%. Out of 1010 Jaundice patients, 370 patients (36.63%) were from urban area and 640 patients (63.36%) were from rural area. Commonest misconception was that the cause of hepatitis is super natural and they go to supernatural healers (Quacks) for treatment, 50% from urban area and 78.12% from rural area had this belief. They follow a special diet, they restrict protein, fat, Yellow Edible things like turmeric and not use full milk, in urban area 70.54% and In Rural area 84.37% had this belief. Knowledge and Awareness about immunisation, safe Injection and safe water was observed in accompanying persons of rural and urban area. it was found that there is less awareness in rural area then urban area. it was observed that there is significant co-relation between knowledge, attitude and behavior of public on the occurrence and complication of jaundice.
Conclusion: It is concluded that there is need to increase the public awareness by different educational programs regarding etiology of hepatitis and its prevention by immunisation for hepatitis A and B, use of safe injection, safe water and hygienic Sanitary habits. Early detection of liver disease and management of case by a competent doctor is the mainstay to decrease the mortality from jaundice. Type of Study: Prospective hospital based mortality.
Keywords
Jaundice, FHF, Hepatitis, ImmunizationReferences
- Nelson Textbook of pediatrics 18th edition volume 2 Page No. 1703-1705.
- Bradley DW, Maynard JE, Popper H et a! : Post transfusion non A non B hepatitis, Physiochemical property of two distinct agents. Infect, dis. 1983; 148: 254-265.
- Raju GS, Broor S. Singh V. and Mehta Sk: Fulminant viral Hepatitis : Indian experience Journal of Gastroenterology and Hepatology 1989; 4 : 161-165.
- Gimson AES, White YS, Eddleston ALWF, Williams R : Clinical and prognostic differences in Fulminant hepatitis type A, B, and non A non B. Gut 1983; 124 : 1194-1198.
- Poddar U, Thapa BR, Prasad A, Sharma AK, Singh K : Natural history and risk factors in fulminant hepatic failure. Arch Dis Child. 2002 Jul;87(1):54-56.
- M.D Yohannan, M. Arif, S. Ramia : Aetiology of Icteric Hepatitis and Fulminant Hepatic Failure in Children and the Possible Predisposition to Hepatic Failure by Sickle Cell Disease. Acta Paediatr Scand 1990;79(2):201-205.
- Thapa BR, Singh K, Singh V, Broor S, Nain CK : Pattern of hepatitis A & hepatitis B virus markers in cases of acute sporadic hepatitis & in healthy school children from North West India : Journal of Tropical Pediatrics, 1995; 41 : 328-329.
- Acute liver failure Gagan k sood, chief editor Julian katz, md medscape reference updated march 2011.
- Ronald A. Sacher, James W. Shih, and Robert H. Pureed : Hepatitis C Virus-Associated Fulminant Hepatic Failure. N Engl J Med 1996; 335:631-634.